Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

5.41USD
4:00pm EDT
Change (% chg)

$0.07 (+1.31%)
Prev Close
$5.34
Open
$5.25
Day's High
$5.42
Day's Low
$5.18
Volume
49,902
Avg. Vol
57,174
52-wk High
$8.68
52-wk Low
$4.85

Latest Key Developments (Source: Significant Developments)

Richmond Brothers Says Support Decision Made By Rockwell Medical
Friday, 25 May 2018 06:25am EDT 

May 25 (Reuters) - Rockwell Medical Inc ::RICHMOND BROTHERS SAYS FULLY SUPPORT DECISION MADE BY ROCKWELL MEDICAL’S BOARD TO TERMINATE ROBERT CHIOINI FROM POSITIONS PRESIDENT & CEO.RICHMOND BROTHERS SAYS ON MAY 24, DELIVERED LETTER TO ROCKWELL MEDICAL BOARD.RICHMOND BROTHERS SAYS BENEFICIALLY OWNS ABOUT 10.9% OF OUTSTANDING SHARES OF ROCKWELL MEDICAL.RICHMOND BROTHERS SAYS SUPPORT TERMINATION OF CFO THOMAS KLEMA’S POSITIONS WITH ROCKWELL MEDICAL - SEC FILING.  Full Article

Rockwell Medical Says CEO Robert Chioini Terminated From Post, Effective Immediately
Thursday, 24 May 2018 04:05pm EDT 

May 24 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL ISSUES STATEMENT.ROCKWELL MEDICAL INC - COMPANY'S PRESIDENT AND CHIEF EXECUTIVE OFFICER, ROBERT CHIOINI, HAD BEEN TERMINATED FROM HIS POSITIONS, EFFECTIVE IMMEDIATELY.ROCKWELL MEDICAL - DECISION TO TERMINATE CHIOINI FOLLOWS A THOROUGH REVIEW OF BUSINESS, INCLUDING AN EVALUATION OF MANAGEMENT.ROCKWELL MEDICAL - MAJORITY OF DIRECTORS DETERMINED CHIOINI "LACKED KEY ATTRIBUTES" NECESSARY TO OVERSEE GROWTH AND LONG-TERM SUCCESS OF CO.ROCKWELL MEDICAL - DESPITE DULY AUTHORIZED TERMINATION BY BOARD, CHIOINI REFUSES TO ACCEPT DECISION.ROCKWELL MEDICAL - CHIOINI TAKEN ACTION PURPORTEDLY ON COMPANY'S BEHALF WITHOUT AUTHORIZATION TO DO SO.ROCKWELL MEDICAL - CHIOINI, CFO THOMAS KLEMA FILED FORM 8-K ON MAY 23 MAKING ASSERTIONS ON 5 INDEPENDENT DIRECTORS WHO VOTED IN FAVOR OF CHIOINI'S REMOVAL.ROCKWELL MEDICAL - WHILE ASSERTIONS IN FILING ARE UNRELATED TO BOARD'S REMOVAL OF CHIOINI, BOARD ACKNOWLEDGES RECEIPT OF PUTATIVE SHAREHOLDER DEMAND LETTER.ROCKWELL MEDICAL INC - PUTATIVE SHAREHOLDER DEMAND LETTER RAISES SUBSTANTIALLY SIMILAR ALLEGATIONS AS THOSE RAISED PERSONALLY BY CHIOINI.ROCKWELL MEDICAL - DUE TO CONDUCT OF KLEMA AFTER TERMINATION OF CHIOINI, 5 INDEPENDENT BOARD DIRECTORS AGREED ON NEED TO REMOVE KLEMA FROM HIS ROLES AT CO.ROCKWELL MEDICAL INC - NOTES THAT NASDAQ HAS REQUESTED ADDITIONAL INFORMATION REGARDING TWO FORM 8-K FILINGS FILED ON MAY 23, 2018.  Full Article

Rockwell Medical CEO Issues Press Release
Wednesday, 23 May 2018 11:25am EDT 

May 23 (Reuters) - Rockwell Medical CEO Rob Chioini::ROCKWELL MEDICAL CEO ISSUES PRESS RELEASE.ROCKWELL MEDICAL CEO ROB CHIOINI SAYS INSTRUCTED CFO TO REMAIN IN CURRENT DUTIES.  Full Article

Rockwell Medical Update On Calcitriol New Manufacturing Submission To FDA
Tuesday, 8 May 2018 08:30am EDT 

May 8 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL UPDATE ON CALCITRIOL NEW MANUFACTURING SUBMISSION TO FDA.ROCKWELL MEDICAL INC - FOR CALCITRIOL VITAMIN D INJECTION, FDA HAS PROVIDED TARGET DATE FOR A RESPONSE TO SUBMISSION OF NO LATER THAN AUG 19, 2018.ROCKWELL MEDICAL - AWARE THAT FDA IS CONDUCTING PRE-APPROVAL INSPECTION OF CONTRACT MANUFACTURING ORGANIZATION'S (CMO'S) LAB PARTNER ON JUNE 25, 2018.ROCKWELL MEDICAL INC - STABILITY DATA THAT WAS PROVIDED IN CALCITRIOL SUBMISSION REMAINS WITHIN SPECIFICATION.ROCKWELL MEDICAL INC - FDA HAS CONFIRMED CALCITRIOL VITAMIN D INJECTION IS UNDER EXPEDITED REVIEW.ROCKWELL MEDICAL INC - NOW AWAITING FDA APPROVAL OF A NEW CONTRACT MANUFACTURER IN ORDER TO COMMERCIALIZE CALCITRIOL.  Full Article

Rockwell Medical Reports Q4 Loss Per Share $0.18
Thursday, 15 Mar 2018 04:01pm EDT 

March 15 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL REPORTS FOURTH QUARTER AND YEAR END 2017 RESULTS.Q4 LOSS PER SHARE $0.18.Q4 SALES ROSE 10.8 PERCENT TO $14.8 MILLION.  Full Article

Rockwell Medical, Inc. Appoints Two Independent Executives To Board Of Directors
Tuesday, 13 Mar 2018 04:34pm EDT 

March 13 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL, INC. APPOINTS TWO INDEPENDENT AND EXPERIENCED LIFE SCIENCES EXECUTIVES TO BOARD OF DIRECTORS.ROCKWELL MEDICAL INC - WOLIN WAS ALSO APPOINTED CHAIRMAN OF BOARD.ROCKWELL MEDICAL - APPOINTED LISA COLLERAN AND BENJAMIN WOLIN TO BOARD OF DIRECTORS, EFFECTIVE MARCH 7, 2018.ROCKWELL MEDICAL INC - ‍REACHED SUPPORT AGREEMENT WITH RICHMOND BROTHERS, AN INVESTMENT ADVISOR THAT IS BENEFICIAL OWNER OF 10.8% OF COMPANY'S STOCK​.ROCKWELL MEDICAL - AGREEMENT OUTLINES SUPPORT FOR CO'S PROPOSAL TO DECLASSIFY BOARD, RESULTING IN DIRECTOR TERMS OF 1 YEAR FOR ALL DIRECTORS.  Full Article

Richmond Brothers Reports 10 Pct Stake In Rockwell Medical
Friday, 9 Mar 2018 04:49pm EST 

March 9 (Reuters) - Richmond Brothers Inc::RICHMOND BROTHERS INC SAYS ON MARCH 7, RICHMOND BROTHERS AND RICHMOND ENTERED INTO LETTER AGREEMENT WITH ROCKWELL MEDICAL INC .RICHMOND BROTHERS SAYS AS PER LETTER AGREEMENT, ROCKWELL MEDICAL BOARD INCREASED TO 8 & LISA COLLERAN & BENJAMIN WOLIN APPOINTED AS DIRECTORS.RICHMOND BROTHERS SAYS ROCKWELL MEDICAL AGREED TO SUBMIT PROPOSAL AT ANNUAL MEETING SEEKING SHAREHOLDER APPROVAL TO DECLASSIFY BOARD.RICHMOND BROTHERS REPORTS A 10 PCT STAKE IN ROCKWELL MEDICAL INC, AS OF MARCH 7 - SEC FILING.  Full Article

Rockwell Medical Signs License Agreement With Quimica Europea To Commercialize Triferic In Peru
Tuesday, 12 Dec 2017 08:30am EST 

Dec 12 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL SIGNS EXCLUSIVE LICENSE AGREEMENT WITH QUIMICA EUROPEA TO COMMERCIALIZE TRIFERIC IN PERU.ROCKWELL MEDICAL - SIGNED LICENSE & MANUFACTURING SUPPLY DEAL WITH QUIMICA EUROPEA FOR RIGHTS TO COMMERCIALIZE TRIFERIC FOR ESRD PATIENTS IN PERU.ROCKWELL MEDICAL INC- QUIMICA EUROPEA WILL BECOME EXCLUSIVE DISTRIBUTOR FOR TRIFERIC IN PERU FOR AN INITIAL COMMERCIAL TERM OF FIVE YEARS.ROCKWELL MEDICAL INC - ROCKWELL RETAINS MANUFACTURING RESPONSIBILITY OF ALL PRODUCTS.ROCKWELL MEDICAL- QUIMICA TO ASSUME ALL REGULATORY RESPONSIBILITIES,RELATED EXPENSES IN OBTAINING GOVERNMENT COMMERCIAL MARKETING APPROVAL FOR TRIFERIC.  Full Article

Richmond Brothers Says On Nov 22, Entered Into Settlement And Standstill Agreement With Rockwell Medical
Monday, 27 Nov 2017 05:36pm EST 

Nov 27 (Reuters) - Rockwell Medical Inc ::RICHMOND BROTHERS INC​ SAYS ON NOVEMBER 22, ENTERED INTO SETTLEMENT AND STANDSTILL AGREEMENT WITH ROCKWELL MEDICAL INC - SEC FILING.RICHMOND BROTHERS-PURSUANT TO SETTLEMENT,STANDSTILL AGREEMENT, ROCKWELL MEDICAL AGREED TO APPOINT, ONE ADDITIONAL MEMBER TO BOARD NO LATER THAN FEB 15, 2018.RICHMOND BROTHERS - STANDSTILL PERIOD SHALL TERMINATE ON FEB 15, 2018 IN EVENT THAT ADDITIONAL DIRECTOR NOT APPOINTED TO BOARD PRIOR TO FEB 15, 2018.RICHMOND BROTHERS - DURING STANDSTILL PERIOD, RICHMOND PARTIES AGREED NOT TO ACQUIRE OVER MORE THAN 12% OF ROCKWELL MEDICAL'S OUTSTANDING SHARES.  Full Article

Rockwell Medical posts Q3 loss of $0.10 per share
Wednesday, 8 Nov 2017 04:01pm EST 

Nov 8 (Reuters) - Rockwell Medical Inc :Rockwell medical reports third quarter results.Q3 loss per share $0.10.Q3 sales rose 14.1 percent to $14.6 million.  Full Article

BRIEF-Rockwell Medical CEO Issues Press Release

* ROCKWELL MEDICAL CEO ROB CHIOINI SAYS INSTRUCTED CFO TO REMAIN IN CURRENT DUTIES Source text for Eikon: Further company coverage: